Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.08 -0.01 (-0.48%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$2.08 +0.00 (+0.24%) As of 08/7/2025 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 12.24%, with a year-to-date return of -14.05%. In the past month, the stock has decreased 0.48%, reflecting recent market activity. As of the latest close, Oramed Pharmaceuticals traded at $2.08 with a market cap of $84.96 million and volume of 99,880 shares. Five years ago, the stock traded at $3.85, representing a 45.97% decrease over that period. At the time, it had a market cap of $91.56 million and a volume of 83,191 shares. Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.89%1 Month Performance-0.48%3 Month Performance-9.17%Year-To-Date Performance-14.05%1 Year Performance-12.24%5 Year Performance-45.97% ORMP Stock Chart for Friday, August, 8, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$2.09$2.08-0.48%$2.13$2.0699,880 shs$84.96 million08/06/2025$2.08$2.09+0.48%$2.12$2.0836,669 shs$85.38 million08/05/2025$2.09$2.08-0.48%$2.12$2.0732,632 shs$84.97 million08/04/2025$2.12$2.09-1.42%$2.14$2.0875,410 shs$85.37 million08/01/2025$2.15$2.12-1.40%$2.18$2.0861,152 shs$86.60 million07/31/2025$2.13$2.15+0.94%$2.19$2.1194,636 shs$87.82 million07/30/2025$2.20$2.13-3.18%$2.21$2.1377,264 shs$87.01 million07/29/2025$2.21$2.20-0.45%$2.25$2.15127,642 shs$89.87 million07/28/2025$2.16$2.21+2.31%$2.26$2.1765,636 shs$90.27 million07/25/2025$2.24$2.16-3.57%$2.24$2.1537,467 shs$88.23 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$2.30$2.24-2.61%$2.30$2.1461,613 shs$91.50 million07/23/2025$2.13$2.30+7.98%$2.30$2.13250,898 shs$93.96 million07/22/2025$2.12$2.13+0.47%$2.18$2.1172,408 shs$87 million07/21/2025$2.12$2.12$2.17$2.1162,017 shs$86.60 million07/18/2025$2.12$2.12$2.15$2.0917,525 shs$86.60 million07/17/2025$2.11$2.12+0.47%$2.15$2.1038,553 shs$86.60 million07/16/2025$2.09$2.11+0.96%$2.11$2.1027,865 shs$86.19 million07/15/2025$2.13$2.09-1.88%$2.14$2.0981,490 shs$85.38 million07/14/2025$2.13$2.13$2.15$2.1156,784 shs$87.01 million07/11/2025$2.12$2.13+0.47%$2.16$2.1018,717 shs$87.01 million07/10/2025$2.17$2.12-2.30%$2.16$2.1126,946 shs$86.60 million07/09/2025$2.09$2.17+3.83%$2.20$2.1176,887 shs$88.64 million07/08/2025$2.16$2.09-3.24%$2.17$2.09104,189 shs$85.38 million07/07/2025$2.18$2.16-1.10%$2.22$2.1442,655 shs$88.24 million Related Companies Candel Therapeutics Stock Chart Monte Rosa Therapeutics Stock Chart Cartesian Therapeutics Stock Chart Foghorn Therapeutics Stock Chart Rocket Pharmaceuticals Stock Chart Inhibrx Biosciences Stock Chart Abeona Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart Altimmune Stock Chart Allogene Therapeutics Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
